Key result
Human induced pluripotent stem cells offer versatile therapeutic and modeling potential without ethical or immune barriers.
Answers are grounded in this paper and cite their sources.
Human induced pluripotent stem cells offer significant potential for disease modeling, regenerative therapy, and drug discovery without the ethical issues of embryonic stem cells.
The prospect of changing the plasticity of terminally differentiated cells toward pluripotency has completely altered the outlook of biomedical research. Human induced pluripotent stem cells (iPSCs) provide a new source of therapeutic cells free from the ethical issues or immune barriers of human embryonic stem cells. iPSCs also confer considerable advantages over conventional methods of studying human diseases. Since its advent, iPSC technology has expanded, with 3 major applications: disease modeling; regenerative therapy; and drug discovery. Here we discuss, in a comprehensive manner, the recent advances in iPSC technology in relation to basic, clinical, and population health.
No takes yet. Share an insight, caveat, or question.
Sayed et al. (2016) reported a review. Human induced pluripotent stem cells (iPSCs) was evaluated. Human induced pluripotent stem cells offer significant potential for disease modeling, regenerative therapy, and drug discovery by providing therapeutic cells free from ethical and immune barriers.
Synapse has enriched 10 related papers. Consider them for comparative context: